Dental Tribune USA
Edition USA
International
Americas
Europe
Asia Pacific
Middle East & Africa

CORONAVIRUS
LIVE UPDATES

COVID-19 business interruption claims: Legal and accounting perspectivesPandemic causing increase in stress-related oral health conditionsCOVID-19 survivors at an increased risk of salivary gland ectasia and oral diseaseHHS launches portal for potential vaccinatorsThe mouth and SARS-CoV-2: Evidence of infected cells suggests key role in infection, transmissionStudy shows dentistry must adapt to be prepared for future crisesHow COVID-19 has forced us all to relook our practices, lives and goalsCanada invests in Septodont’s pharma division to combat COVID-19EFP survey reveals effect of COVID-19 on periodontal practiceVaccine nationalism poses threat to global health
Visit microsite
home / who’s who

Robert Selleck (DTA)

Company: Dental Tribune America
Address: 118-35 Queens Blvd, Ste 400, Forest Hills, United States
Phone:
Fax:
Website: https://us.dental-tribune.com/
Email: r.selleck@dental-tribune.com

Short CV

Robert Selleck is Managing Editor/Designer at Dental Tribune U.S. and Dental Tribune Canada.

advertisement
Content you may be interested in:

February 24, 2021 | News

ADA announces commencement of 2021 Give Kids a Smile program

The 19th annual Give Kids a Smile program virtually kicked off this month with more than 1,000 events across the country providing free dental health care to thousands of underserved children with the help of more than 8,100 dentists and 17,000 dental health team members.

details

November 9, 2020 | Education, News

Webinar to present expert consensus on risk factors for predictable osseointegration

ARLINGTON HEIGHTS, Ill., USA: On Nov. 18, the Academy of Osseointegration (AO) will host a complimentary live Zoom webinar to discuss the latest literature and research surrounding its most recent summit: “Optimized Patient Care, Converting Osseointegration to Patientintegration.”

details

June 22, 2020 | Business

Michael Rynerson appointed CEO of ACTEON

BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.

details
International
Americas
Europe
Asia Pacific
Middle East & Africa

© 2021 - All rights reserved - Dental Tribune International